Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

Regeneron Pharmaceuticals has announced results from the phase 3 QUASAR trial and its extension study of the phase 3 PULSAR ...

Modern Retina - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic community.

Over the past several decades, vision researchers have recognized that cerebral/cortical visual impairment (CVI) is a leading cause of pediatric visual impairment in the US and other industrialized ...

ARCATUS or ARVN001, in Greater China, South Korea, Australia, New Zealand, India and the ASEAN Countries is formally known as XIPERE in the United States and was developed by Clearside Biomedical.

As part of the Johns Hopkins Wilmer Eye Institute’s MACULA 2025 and the 5th Annual Retina Festival, Christina Y. Weng, MD, MBA, gave a presentation titled “Home Monitoring for Age-Related Macular ...

A look at the current state of AI in diabetic eye disease and where the future may take us. Artificial intelligence (AI) and deep learning tools are now a part of many people’s daily lives, whether ...

Aurion Biotech, Inc. has appointed Donald Munoz as chief financial officer (CFO). Greg Kunst, Aurion’s CEO, commented on this news in the company’s press release 1, saying, “We are delighted to ...

Panelists discuss how loading doses remain crucial for treatment-naive patients to achieve rapid disease control, while patients switching therapies may require modified approaches based on their ...

Panelists discuss how real-world evidence provides crucial insights into treatment effectiveness across diverse patient populations and clinical settings while highlighting challenges in maintaining ...